Skip to main content
An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.
Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
Array comparative genomic hybridization analysis in patients with anophthalmia, microphthalmia, and coloboma.
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.
Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey.
Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray.
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome).
Fryns syndrome: report of eight new cases.
Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation.